AU2002212888A1 - Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4) - Google Patents

Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4)

Info

Publication number
AU2002212888A1
AU2002212888A1 AU2002212888A AU1288802A AU2002212888A1 AU 2002212888 A1 AU2002212888 A1 AU 2002212888A1 AU 2002212888 A AU2002212888 A AU 2002212888A AU 1288802 A AU1288802 A AU 1288802A AU 2002212888 A1 AU2002212888 A1 AU 2002212888A1
Authority
AU
Australia
Prior art keywords
agonist
composition
receptor antagonists
serotonin receptor
serotonin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002212888A
Other languages
English (en)
Inventor
Staffan Skogvall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Respiratorius AB
Original Assignee
Respiratorius AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003995A external-priority patent/SE0003995D0/xx
Application filed by Respiratorius AB filed Critical Respiratorius AB
Publication of AU2002212888A1 publication Critical patent/AU2002212888A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002212888A 2000-11-01 2001-10-30 Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4) Withdrawn AU2002212888A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24466100P 2000-11-01 2000-11-01
US60244661 2000-11-01
SE0003995A SE0003995D0 (sv) 2000-11-01 2000-11-01 Receptoragonister och antagonister
SE0003995 2000-11-01
PCT/SE2001/002372 WO2002036113A1 (fr) 2000-11-01 2001-10-30 Composition comprenant des agonistes (5ht-4) et des antagonistes (5ht-2, 5ht-3) recepteurs de la serotonine

Publications (1)

Publication Number Publication Date
AU2002212888A1 true AU2002212888A1 (en) 2002-05-15

Family

ID=26655284

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212888A Withdrawn AU2002212888A1 (en) 2000-11-01 2001-10-30 Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4)

Country Status (2)

Country Link
AU (1) AU2002212888A1 (fr)
WO (1) WO2002036113A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160898B2 (en) 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
AU2005224160A1 (en) * 2004-03-17 2005-09-29 Sosei R&D Ltd. The treatment of inflammatory disorders and pain using beta-aminoalcohols
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US20060069124A1 (en) * 2004-09-07 2006-03-30 Rao P S Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases
WO2006052889A2 (fr) 2004-11-05 2006-05-18 Theravance, Inc. Composes de quinolinone-carboxamide
JP5086091B2 (ja) 2004-11-05 2012-11-28 セラヴァンス， インコーポレーテッド ５−ｈｔ４受容体アゴニスト化合物
CN101132777A (zh) 2004-12-20 2008-02-27 科利吉姆制药公司 用于睡眠障碍的药物组合物
JP5159317B2 (ja) 2004-12-22 2013-03-06 セラヴァンス， インコーポレーテッド インダゾール−カルボキサミド化合物
ES2523851T3 (es) 2005-03-02 2014-12-02 Theravance Biopharma R&D Ip, Llc Compuestos de quinolinona como agonistas de los receptores 5-HT4
KR20100026641A (ko) * 2008-09-01 2010-03-10 동아제약주식회사 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법
GB0901487D0 (en) 2009-01-30 2009-03-11 Movetis N V Asthma Therapy
CA3177454A1 (fr) 2020-05-19 2021-11-25 Cybin Irl Limited Derives de tryptamine deuteres et procedes d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042395B1 (es) * 1992-02-27 1994-06-16 Promotora Catalana De Inversio Procedimiento para la obtencion de derivados de 2-ciano-3-piperacinilquinoxalinas.
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DK1066036T3 (da) * 1998-02-27 2006-08-21 Univ Illinois Midler med serotoninrelateret aktivitet til behandling af sövnapnö
EP1185263A2 (fr) * 1999-06-15 2002-03-13 Respiratorius AB Agonistes et antagonistes de recepteurs

Also Published As

Publication number Publication date
WO2002036113A1 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
PL366233A1 (en) Substituted pyridoindoles as serotonin agonists and antagonists
AU2002347022A1 (en) Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
AU2002366384A1 (en) Insulin and igf-1 receptor agonists and antagonists
AU2002212888A1 (en) Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4)
AU4426599A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the D1 receptors
HUP0201033A2 (hu) Glukagon antagonisták és inverz agonisták, eljárás az előállításukra és alkalmazásuk
AU2001287574A1 (en) Human g protein-coupled receptor igpcr20, and uses thereof
AU2002223501A1 (en) Glucagon antagonists/inverse agonists
MXPA03005257A (es) Composiciones frarmaceuticas de un agonista del receptor de nmda.
IL152700A0 (en) Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists
HK1057536A1 (en) New combination of serotonin agonist (5ht2) and antagonist (5ht6) as pharmaceutical formulation
AU2002223500A1 (en) Glucagon antagonists/inverse agonists
EP1453503A4 (fr) Agoniste du recepteur ep4, compositions et procedes associes
AU2001264657A1 (en) Crf receptor antagonists
AU2002211176A1 (en) Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3
HUP0300419A3 (en) Estrogen agonist/antagonist metabolites, pharmaceutical compositions containing them and their use
AU2002351730A1 (en) Glucagon receptor antagonists/inverse agonists
AU2001290772A1 (en) Alpha v integrin receptor antagonists
AU2001286409A1 (en) N-methyl-d-aspartate receptor antagonists
HUP0100926A3 (en) Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
AU1652601A (en) New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist
HUP0303513A3 (en) Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonists and antagonists, their use and pharmaceutical compositions containing them
AU2002226048A1 (en) Urotensin-ii receptor antagonists
AU2001225663A1 (en) A composition comprising a combination of receptor agonists and antagonists
AU2002239506A1 (en) Urotensin-ii receptor antagonists